查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1548114

全球胜肽合成市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Peptide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2032年，全球胜肽合成市場的市場規模將從2023年的6.9069億美元達到近22.639億美元，2024-2032年研究期間的複合年成長率為14.1%。

胜肽具有廣泛的生物功能，例如抗氧化特性、荷爾蒙功能、抗菌劑、臨床診斷，並且還可作為生長因子。此外，由於其特異性高、化學空間大、易於合成、生物活性、低毒性和易於獲得，它們也作為潛在的活性藥物成分用於藥物開發。它們也被用於治療多種疾病，包括心血管疾病、癌症、呼吸系統疾病等。由於胜肽生產中的各種技術進步，肽分子在營養和醫療保健行業中獲得了巨大的發展動力。例如，化學合成被認為是傳統且廣泛使用的胜肽合成技術；然而，該過程缺乏特異性，增加了環境負擔的風險。因此，這導致了酶法技術用於肽合成的應用。

市場動態

肽在藥品生產中的使用不斷增加推動了市場的成長。肽是具有多種生物功能的高度特異性和活性藥物，被廣泛應用於治療領域。糖尿病、腫瘤學和肥胖症是胜肽產生數十億美元利潤的三大治療領域。根據美國國家癌症研究所的研究，2018年美國診斷出1,735,350例癌症病例。因此，疾病狀況的上升推動了全球胜肽合成市場的成長。此外，肽合成市場研發活動的增加也有助於市場成長。為了克服全球健康挑戰，研究實體的參與和對先進創新生物基產品的投資不斷增加，對市場成長產生了積極影響。然而，胜肽合成過程中的污染問題加上監管標準缺乏升級，限制了市場的發展。多家公司正在開發先進的胜肽生產技術，預計在未來幾年為市場創造利潤豐厚的機會。例如，New England Peptide Inc.使用名為Pep Trend系統的獨特軟體程式來設計和生產客製化胜肽。

該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。

此外，這些工具還對全球肽合成市場中的每個應用/產品領域進行包容性評估。

市場區隔

整個胜肽合成市場已細分為產品、應用、技術和最終用戶。該報告根據地理細分對這些子集進行了分析。這項研究將使行銷人員了解情況，並有助於確定產品或服務的目標族群。

按產品分類

  • 設備（胜肽合成儀、冷凍乾燥機、層析設備等）
  • 試劑及耗材
  • 其他

依技術

  • 固相胜肽合成（SPPS）
  • 液相肽合成 (LPPS)
  • 混合技術

按申請

  • 治療學（癌症、代謝、心血管疾病、呼吸系統、GIT（胃腸道疾病）、傳染病、疼痛、皮膚科、中樞神經系統、腎臟、其他）
  • 診斷
  • 研究

按最終用途

  • 製藥與生物技術公司
  • 合約開發和製造組織/合約研究組織
  • 學術及研究機構
  • 區域分析

本節涵蓋區域細分，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的胜肽合成市場當前和未來的需求。此外，該報告重點關注所有主要地區對個別應用領域的需求。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。胜肽合成市場的主要參與者包括Genscript Biotech、Merck KGaA、Bachem Holdings、Biotage、CEM Corporation、Thermo Fisher、Creative Diagnostics、Polypeptide Group、Syngene、PuroSynth、Lonza、MP Biomedicals 和Novo Nordisk A/S。本節包括競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：胜肽合成 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球胜肽合成市場分析：按產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 設備（胜肽合成儀、冷凍乾燥機、層析設備等）
  • 試劑及耗材
  • 其他

第 6 章：全球胜肽合成市場分析：依技術分類

  • 依技術概述
  • 歷史和預測數據
  • 技術分析
  • 固相胜肽合成（SPPS）
  • 液相肽合成 (LPPS)
  • 混合技術

第 7 章：全球胜肽合成市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 治療學（癌症、代謝、心血管疾病、呼吸系統、GIT（胃腸道疾病）、傳染病、疼痛、皮膚科、中樞神經系統、腎臟、其他）
  • 診斷
  • 研究

第 8 章：全球胜肽合成市場分析：依最終用途

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 製藥與生物技術公司
  • 合約開發和製造組織/合約研究組織
  • 學術及研究機構

第 9 章：全球胜肽合成市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第10章：胜肽合成公司的競爭格局

  • 多肽合成市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Genscript Biotech
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bachem Holdings
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Biotage
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • CEM Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Creative Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Polypeptide Group
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Syngene
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PuroSynth
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Lonza
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • MP Biomedicals And Novo Nordisk A/S.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11211390

The global demand for Peptide Synthesis Market is presumed to reach the market size of nearly USD 2263.9 Million by 2032 from USD 690.69 Million in 2023 with a CAGR of 14.1% under the study period 2024 - 2032.

Peptides possess broad range of biological functions such as anti-oxidant properties, hormonal functions, antimicrobial agents, clinical diagnosis, and also act as growth factors. Furthermore, they are also used in drug development as potential active pharmaceutical ingredients owing to their high specificity, large chemical space, ease of synthesis, biological activity, low toxicity, and ready availability. They are also exploited in the treatment of several diseases including cardiovascular diseases, cancer, respiratory disorders, and others. Peptide molecules gained immense momentum in nutrition and healthcare industries attributed to the various technological advancements in the peptide production. For instance, chemical synthesis is considered as the traditional and widely used technology for peptide synthesis; however, the process lacked specificity and increased the risk of environmental burdens. Therefore, this caused the adoption of enzymatic technology for peptide synthesis.

Market Dynamics

Escalating usage of peptides in the production of pharmaceutical drugs propels the market growth. Peptides are highly specific and active drugs with diverse biological functions that are used in a broad range of therapeutic areas. Diabetes, oncology, and obesity are the three major therapeutic areas in which peptides generate profits in billions of dollars. According to the research study by National Cancer Institute, 1,735,350 cancer cases were diagnosed in the U.S in 2018. Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity. Therefore, rising disease conditions boost the growth of global peptide synthesis market. Moreover, the increase in research & development activities in the peptide synthesis market also contributes to the market growth. The rising participation of research entities and investment for the advanced and innovative bio-based products in order to overcome the global health challenges positively influences the market growth. However, contamination issues during the course of peptide synthesis coupled with lack of upgradation in regulatory standards acts as a restrain for the market progression. Various companies are developing advanced technologies for peptide production, and it is anticipated to create lucrative opportunities for the market in the coming years. For example, New England Peptide Inc. uses a unique software program named Pep Trend system, to design and produce custom peptides.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peptide synthesis.

Market Segmentation

The entire peptide synthesis market has been sub-categorized into product, application, technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others)
  • Reagents & Consumables
  • Other

By Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Application

  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others)
  • Diagnosis
  • Research

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organization/Contract Research Organization
  • Academic & Research Institutes
  • Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for peptide synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peptide synthesis market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PEPTIDE SYNTHESIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Historic and Forecast Sales By Regions
  • 5.5. Reagents & Consumables Historic and Forecast Sales By Regions
  • 5.6. Other Historic and Forecast Sales By Regions

6. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Technology
  • 6.4. Solid Phase Peptide Synthesis (SPPS) Historic and Forecast Sales By Regions
  • 6.5. Liquid Phase Peptide Synthesis (LPPS) Historic and Forecast Sales By Regions
  • 6.6. Hybrid Technology Historic and Forecast Sales By Regions

7. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Historic and Forecast Sales By Regions
  • 7.5. Diagnosis Historic and Forecast Sales By Regions
  • 7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Contract Development & Manufacturing Organization/Contract Research Organization Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEPTIDE SYNTHESIS COMPANIES

  • 10.1. Peptide Synthesis Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PEPTIDE SYNTHESIS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Genscript Biotech
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Merck KGaA
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bachem Holdings
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Biotage
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. CEM Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Thermo Fisher
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Creative Diagnostics
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Polypeptide Group
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Syngene
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. PuroSynth
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Lonza
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. MP Biomedicals And Novo Nordisk A/S.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Peptide Synthesis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Peptide Synthesis Report
  • Market Research Process
  • Market Research Methodology
  • Global Peptide Synthesis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.